AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and General Counsel Nicole R. Hadas sold $77K of Akebia Therapeutics, Inc.
Sold$77,270
$1.22Price
63,186Shares
−11%Stake
What AKBA did after the filing
- The stock from Fri, May 26 open, $1.21
- −5.8%
- S&P 500, same days
- +7.8%
Measured over 30 trading days, to the Jul 12 close.
Traded Thu, May 25. Filed Thu, May 25, 5:01 PM ET, after the close. Returns use the May 26 open and the Jul 12 close. Not investment advice.